Tyson Foods Plans 19 Employee Vaccination Events Across Arkansas

Free, on-site vaccinations will be offered for team members

SPRINGDALE, Ark., March 15, 2021 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) is expanding its free, onsite COVID-19 vaccinations to all team members in the state of Arkansas, where 20 percent of the company’s U.S. workforce is based. March 15 through April 2, the company will hold 19 vaccination events to ensure the company’s 24,000 Arkansas employees have convenient access to the vaccine.

The vaccines are being provided in conjunction with Matrix Medical, local health departments and other healthcare providers where food processing workers are among the priority groups now eligible for vaccination.

“We’re pleased to offer our team members convenient access to the vaccine and are committed to a long-term strategy that ensures any team member who wants a vaccine will receive one,” said Tom Brower, senior vice president of Health and Safety for Tyson Foods. “We’re focused on educating and encouraging our team members to be vaccinated and will continue to leverage both onsite events and our relationships with local health departments to make the vaccine easily accessible.”

Additional vaccination events are planned this week for Tyson team members in San Lorenzo, California, Rochelle, Illinois, Noel, Missouri and Enid, Oklahoma.

Over the past two weeks, 15,000 of the company’s U.S. employees have been vaccinated at 30 onsite events across the country. This includes more than 1,200 team members who were vaccinated March 9 and 10 at Tyson facilities in Fayetteville and Springdale, Arkansas. Photos, b-roll and team member interviews from the Fayetteville event are available for download.

In preparation for vaccinations, Tyson Foods has been providing expert resources and education about the vaccine to team members. This information is available in multiple languages and team members also have access to a hotline to ask questions. In addition to offering free, on-site vaccinations, the company also recently announced that it is compensating workers for up to four hours of regular pay if they are vaccinated outside of their normal shift or through an external source.

Tyson Foods’ vaccination efforts are the latest in a series of measures the company has taken to fight COVID-19. Since the spring of 2020, the company invested hundreds of millions of dollars to transform its U.S. facilities with protective measures, from walk-through temperature scanners and workstation dividers to social distance monitors and always-on testing, as well as provide additional team member pay and benefits. Tyson Foods has also expanded its health services staff, added a chief medical officer and plans to pilot health clinics for team members and their families early this year.

Tyson Foods continues to experience success in its efforts to protect workers from the virus. The incidence of the virus involving the company’s U.S. team members remains very low.

About Tyson Foods

Tyson Foods, Inc. (NYSE: TSN) is one of the world’s largest food companies and a recognized leader in protein. Founded in 1935 by John W. Tyson and grown under three generations of family leadership, the company has a broad portfolio of products and brands like Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, Aidells®, ibp®, and State Fair®. Tyson Foods innovates continually to make protein more sustainable, tailor food for everywhere it’s available and raise the world’s expectations for how much good food can do. Headquartered in Springdale, Arkansas, the company has 139,000 team members. Through its Core Values, Tyson Foods strives to operate with integrity, create value for its shareholders, customers, communities and team members and serve as a steward of the animals, land and environment entrusted to it. Visit TYSONFOODS.COM to learn more.

Contact: Derek Burleson, 479-290-6466



Cape Fox Lodge and Baranof Fishing Partner to Bring Back Adventure!

Ketchikan, Alaska, March 15, 2021 (GLOBE NEWSWIRE) — After spending over a year at home, are you looking to bring back vacation and adventure? Cape Fox Lodge and Baranof Fishing are partnering to bring the adventure back to your life in Alaska. 

Now is the time to cast away your troubles and have that Alaskan adventure you have always wanted to take.  Cape Fox Lodge is a luxurious retreat that has been providing food and lodging for traveling friends and guests for over 30 years.  By partnering with Baranof fishing, we can give you lavish accommodations and fishing tour packages at reasonable prices.

Cape Fox Lodge and Baranof Fishing are offering our adventure friends the five best things to attract you to make Ketchikan your adventure destination:

  • Stay for four nights in a water view room with double occupancy
  • Receive a gift card good for any of the Cape Fox family of restaurants or the Baranof Alaska Fish House
  • Two days of fishing for two people (six hours/day)
  • Transportation to and from the airport ferry and daily rides to the fishing boats
  • The new personal Cape Fox Lodge Concierge Service to help the guest through their entire stay

 

We are partnering together to you more adventure without more prices. After a year at home, come to Ketchikan, Alaska, to bring back the adventure.

For additional information, call (907) 617-9579.

                                                 

About Cape Fox Corporation                                           

                                                     

Cape Fox Corporation (CFC) was formed as part of the Alaska Native Claims Settlement Act (ANCSA) of 1971. Cape Fox Corporation is the Alaska Native Corporation for the village of Saxman.

Today, Cape Fox Corporation is comprised of a family of businesses divided between two distinct groups: The Federal Contracting Group and The Commercial (Tourism) Group. Collectively, CFC and its subsidiaries specialize in tourism, information technology and cybersecurity; professional services; health care services; marketing; training services, and logistical services.

 

Visit Cape Fox Corporation to learn more.



Heather Kaiser
Cape Fox Corporation
703.686.2340
[email protected]

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Clover Health Investments (CLOV) Investors of Securities Fraud Lawsuit and April Deadline, Encourages Investors with Losses to Contact its Attorneys

SAN FRANCISCO, March 15, 2021 (GLOBE NEWSWIRE) — Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.   A securities fraud class action has been filed and certain investors may have valuable claims.

Class Period: Oct. 6, 2020 – Feb. 3, 2021
Lead Plaintiff Deadline: Apr. 6, 2021
Visit:www.hbsslaw.com/investor-fraud/CLOV
Contact An Attorney Now:[email protected]
         844-916-0895

Clover Health Investments, Corp. (CLOV) Securities Class Action:

The Complaint alleges that, throughout the Class Period, Defendants misrepresented and concealed that: (1) Clover’s Clover Assistant platform was under investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; (2) the DOJ’s investigation presented an existential risk to Clover because it derives most of its revenues from Medicare; and (3) Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology.

Investors allegedly began to learn the truth on Feb. 4, 2021 when Hindenburg Research released a scathing report about the company, alleging Clover’s sales are the product of misleading marketing activities targeting the elderly and a major undisclosed related party deal.

Hindenburg claimed that Clover concealed that the DOJ is actively investigating the company for illegal kickbacks and deceptive marketing practices. Hindenburg alleged that the company uses a subsidiary, Seek Insurance Services, to misleadingly steer seniors toward acquiring Clover plans. Citing accounts from former employees, Hindenburg further stated “that much of Clover’s sales are fueled by a major undisclosed relationship between Clover and [B&H Assurance,] an outside brokerage firm controlled by Clover’s Head of Sales (Hiram Bermudez).”

The next day, Clover admitted it was fully aware of the DOJ inquiry and Bermudez’s ownership in B&H Assurance. The company also revealed that it received a letter from the SEC following Hindenburg’s report.

On this news, the price of Clover shares sharply declined.

“We’re focused on investor losses and whether Clover may have misled investors about the legality of its business practices and related financial reporting,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Clover shares, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Clover should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30% of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].


About Hagens Berman


Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation.   More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895



Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Renewable Energy Group, Inc.

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Renewable Energy Group, Inc.

OKLAHOMA CITY–(BUSINESS WIRE)–
Federman & Sherwood announces that on March 2, 2021, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Renewable Energy Group, Inc. (NASDAQ: REGI). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is May 3, 2018 through February 25, 2021.

To learn how to participate in this action, please visit https://www.federmanlaw.com/blog/federman-sherwood-announces-the-filing-of-a-securities-class-action-lawsuit-against-renewable-energy-group-inc/.

Plaintiff seeks to recover damages on behalf of all Renewable Energy Group, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, May 3, 2021 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:

Robin Hester

FEDERMAN & SHERWOOD

10205 North Pennsylvania Avenue

Oklahoma City, OK 73120

Email to: [email protected]

Or, visit the firm’s website at www.federmanlaw.com

Robin Hester

[email protected]

KEYWORDS: United States North America Oklahoma

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies Athenex (ATNX) Investors of Filing of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact Its Attorneys

SAN FRANCISCO, March 15, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now.

Class Period: Aug. 7, 2019 – Feb. 26, 2021
Lead Plaintiff Deadline: May 3, 2021
Visit:www.hbsslaw.com/investor-fraud/ATNX
Contact An Attorney Now:[email protected]
         844-916-0895

Athenex, Inc. (NASDAQ: ATNX) Securities Class Action:

The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer.

Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the primary endpoint of objective response rate (ORR), which might have introduced unmeasured bias and influence on the blinded independent central review (BICR); (iii) the Company’s Phase 3 study did not include a representative population; and (v) as a result, it was foreseeable that the FDA would not approve the Company’s NDA in its current form.

On Mar. 1, 2021, the market learned the truth when Athenex announced it received the FDA’s complete response letter (“CRL”) to the NDA for oral paclitaxel plus encequidar. In the CRL, the FDA cited safety risks to patients in terms of an increase in neutropenia-related sequalae. The CRL also cited uncertainty over the results of the primary endpoint of the ORR at week 19, which might have introduced unmeasured bias and influence on the BICR. The FDA further recommended that “Athenex conduct a new adequate and well-conducted clinical trial in a patient population with metastatic breast cancer representative of the population in the U.S.”

On this news, shares of Athenex stock fell approximately 55% in one day.

“We’re focused on investors’ losses and proving Athenex intentionally misled investors about its leading drug candidate,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are an Athenex investor and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Athenex should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].


About Hagens Berman


Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation.   More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895




What:

 BofA Global Research Global Industrials Conference 2021


      When:

 Tuesday, March 16th, 2021 at 10:50am ET


What:

 Stifel 2021 Cross Sector Insight Conference


      When:

 Tuesday, June 8th, 2021


What:

 Baird 2021 Global Consumer, Technology & Services Conference


      When:

 Wednesday, June 9th, 2021


What:

 Nasdaq 44th Virtual Investor Conference


      When:

 Wednesday, June 16th, 2021

To view the webcast for conferences please use the link below.


Webcast:

 www.ptc.com/for/investors.htm


Replay: 

 To access the replay via webcast, please visit www.ptc.com/for/investors.htm.

Please note that statements made at each conference are as of the date of the respective conference and PTC does not assume any obligation to update any statements made live or the archived calls. Matters discussed may include forward-looking statements about PTC’s anticipated financial results and growth, as well as about the development of products and markets, which are based on current plans and assumptions. Actual results in future periods may differ materially from current expectations due to a number of risks and uncertainties, including those described from time to time in reports filed by PTC with the U.S. Securities and Exchange Commission, including PTC’s most recent reports on Form 10-K and 10-Q.


About PTC

 

PTC (NASDAQ: PTC) PTC enables global manufacturers to realize double-digit impact with software solutions that enable them to accelerate product and service innovation, improve operational efficiency, and increase workforce productivity. In combination with an extensive partner network, PTC provides customers flexibility in how its technology can be deployed to drive digital transformation – on premises, in the cloud, or via its pure SaaS platform. At PTC, we don’t just imagine a better world, we enable it.

PTC.com
           
@PTC
           
Blogs


PTC Investor Relations Contact
              

PTC and the PTC logo are trademarks or registered trademarks of PTC Inc. or its subsidiaries in the United States and other countries.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ptc-to-participate-in-upcoming-investor-conferences-301247588.html

SOURCE PTC Inc.

Peach Medical Sourcing Delivers 70mm PPE Units, Hiring 45 Staff for 2021 Scale-Up

Peach Medical Sourcing has unveiled ambitious plans to recruit 45 sales executives as it continues to roll out its technological supply chain solutions across the US in 2021.

LOS ANGELES, March 15, 2021 (GLOBE NEWSWIRE) — Peach Medical Sourcing has unveiled ambitious plans to recruit 45 sales executives as it continues to roll out its technological supply chain solutions across the US in 2021. 

The medical supply specialist delivered 70 million Personal Protective Equipment (PPE), testing and medical supplies in 2020.  

This was capped with 13 million mask donations to more than 50 non-profits and religious organizations throughout the Los Angeles area, including organizations such as Boys and Girls Club, Sacred Heart Foundation, and United Farm Workers. 

IG post: https://www.instagram.com/p/CF9FEyqlUEQ/

Small minority-owned joint venture Peach Medical Sourcing, along with its partners TrueVision Tech and Terratori, has announced the nationwide hiring of 45 mid-market sales executives, 300 additional SKUs, and national distribution via six new fulfilment centers.  

The joint venture executive team has shown its commitment to compete with large pubic traded medical supply chain companies and utilize its $200 million of cash on hand and credit line to deliver on PO and net-terms to end clients. 

Nitin Khosla, CEO of Peach Medical Sourcing, said: “2020 was an excellent year for us in implementing a sales and marketing structure that catered to large healthcare organizations, GPOs, and Government clients on all levels.  

“What was lacking was the attention to small- to medium-sized medical practices and organizations, rural hospitals, and guidance to educational institutions.”  

Khosla, a veteran Fintech executive, added: “Medical supply companies have continued to restrict allocation buying to these groups in 2021, which we don’t align ourselves with. Our nationwide sales team, powered by our six new distribution centers, is excited to become a trusted source and vendor to these groups.” 

Tarun Raj, CEO of Terratori, an emergency management vetting platform that was quickly tailored to the needs of the pandemic, added: “Being a native of Los Angeles, and leader of our West Coast operation, my duty was to vet out suppliers, importers, and manufacturers.  

“Daily, we still see fraud and counterfeit in the PPE space, most recently the 13 million 3M masks that were distributed throughout the country. Due to our track record and experience, we frequently consult with regulatory agencies on identifying the bad actors.” 

He added: “We have established a consistent, compliant supply chain of imported goods and have now moved our efforts into 2021 to add SKU’s monthly of medical supplies, PPE, and other office goods for mass distribution.  

“We also are making a concerted effort to purchase and distribute domestic-made goods, and launching in partnership a domestic manufacturing nitrile glove factory in Q2 and Q3.” 

“Since the beginning of the pandemic, many governments and healthcare organizations were failed by vendors, brokers, suppliers and manufacturers on the delivery of goods,” reflected Aji Eapen, CEO of TrueVision Tech, a minority-owned small business with 13+ years of experience servicing government clients and contracts. 

“Due to competition between government and healthcare organizations, many had to change how they operate on the payment terms, most times having to front deposits and full payment for delivery.  

“Even then, items would not be delivered due to misrepresentation or delays. Into 2021, the successful supplier and vendor to all types of organizations will have goods consistently coming in and the ability to offer payment terms to buyers.”

He concluded: “By locking in our consistent supply chain of all PPE goods, our cash on hand, financing, and proven track record, we’re poised to make a distribution in the market place.”

For more information, 
Nitin Khosla
CEO, Peach Medical Sourcing
Email: [email protected]

Peach Medical Sourcing: Peachmedicalsourcing.com 

Terratori: Terratori.com

True Vision Tech: https://truevisiontech.com/ 

Previous article Link:
https://news.yahoo.com/sera-labs-terratori-technologies-getting-183000574.html

IG post:
https://www.instagram.com/p/CF9FEyqlUEQ/?utm_source=ig_web_copy_link

For the original news story, please visit https://www.prdistribution.com/news/peach-medical-sourcing-delivers-70mm-ppe-units-hiring-45-staff-for-2021-scale-up-2.html

Attachment



Media Company: Peach Medical Sourcing, Media Name: Nitin Khosla | CEO, Media Phone: 240.447.5202, Media Email: [email protected]

SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc.

PR Newswire

NEW YORK, March 15, 2021 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics, Inc. (“GenMark” or the “Company”) (NASDAQ: GNMK) in connection with the proposed acquisition of the Company by Roche Holdings, Inc., a global pioneer in pharmaceuticals and diagnostics. The transaction is structured as an all-cash tender offer in which the Company’s shareholders will receive $24.05 for each share of GenMark that they hold.


If you own GenMark shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

https://www.weisslawllp.com/GNMK/


Or please contact:



Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw LLP is investigating whether GenMark’s board acted in the best interest of GenMark’s public shareholders in agreeing to the proposed transaction, whether the $24.05 offer price adequately compensates GenMark’s shareholders, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to GenMark’s public shareholders.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected] 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-genmark-diagnostics-inc-301247565.html

SOURCE WeissLaw LLP

Healthcare Trust of America, Inc. Announces its First Quarter Dividend

PR Newswire

SCOTTSDALE, Ariz., March 15, 2021 /PRNewswire/ — Healthcare Trust of America, Inc. (NYSE:HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that its Board of Directors issued a quarterly dividend of $0.320 per share of common stock.  This represents an annualized rate of $1.28 per share of common stock with an annualized yield of 4.55% based on HTA’s closing share price as of March 12, 2021.  The dividend will be paid on April 12, 2021 to stockholders of record on April 2, 2021.

Additionally, the eligible holders of HTA’s operating partnership units (“OP Units”) will receive a quarterly OP Unit distribution, which is on par with HTA’s common stock dividend described above.

The amount of common stock dividends HTA pays to its stockholders is subject to the review and approval of the Company’s Board of Directors at its discretion, and is dependent on a number of factors, including funds available for the payment of distributions, HTA’s financial condition, capital expenditure requirements and annual distribution requirements needed to maintain HTA’s status as a real estate investment trust under the Internal Revenue Code.  HTA’s Board of Directors may reduce its dividend rate and HTA cannot guarantee the amount of dividends paid in the future, if any.

About HTA

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings in the United States, comprising approximately 25.4 million square feet of GLA, with $7.5 billion invested primarily in medical office buildings as of December 31, 2020.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.  More information about HTA can be found on the Company’s Website (www.htareit.com), Facebook, LinkedIn, Instagram and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements.  Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.

The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA’s control.  Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA’s actual results and performance could differ materially and in adverse ways from those set forth in the forward-looking statements.  Factors which could have a material adverse effect on HTA’s operations and future prospects include, but are not limited to:

  • the Company’s ability to effectively deploy proceeds of offerings of securities;
  • changes in economic conditions affecting the healthcare property sector, the commercial real estate market and the credit market;
  • competition for acquisition and development of medical office buildings and other facilities that serve the healthcare industry;
  • the Company’s ability to acquire or develop real properties, and to successfully operate those properties once acquired or developed;
  • pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic;
  • economic fluctuations in certain states in which the Company’s investments are geographically concentrated;
  • financial stability and solvency of the Company’s tenants, including the ability and willingness of the Company’s tenants or borrowers to satisfy obligations under their respective contractual arrangements with the Company and the potential inability of the Company to enforce its rights under its leases during the pendency of any pandemic;
  • the ability and willingness of the Company’s tenants to renew their leases with the Company upon expiration of the leases or the Company’s ability to reposition its properties on the same or better terms in the event of a nonrenewal or in the event the Company exercises its right to replace an existing tenant;
  • fluctuations in reimbursements from third party payors such as Medicare and Medicaid;
  • supply and demand for operating properties in the market areas in which the Company operates;
  • changes in operating expenses of the Company’s properties including, but not limited to, expenditures for property taxes, property and liability insurance premiums, and utility rates;
  • the Company’s ability and the ability of its tenants to obtain and maintain adequate property, liability and other insurance from reputable, financial stable providers;
  • restrictive covenants on certain of the Company’s properties subject to ground leases that may restrict or limit the uses of its properties and the types of tenants the Company is able to lease to, and the Company’s ability to attract new tenants;
  • the impact from damage to the Company’s properties from, or increased operating costs associated with, catastrophic weather and other natural events and the physical effect of climate change;
  • retention of the Company’s senior management team and its ability to attract and retain qualified key personnel;
  • legislative and regulatory changes, including changes to laws governing the taxation of real estate investment trusts (“REITs”) and changes to laws governing the healthcare industry;
  • changes in interest rates, including changes as a result of the phasing out of the London Inter-bank Offered Rate (“LIBOR”) effective June 30, 2023;
  • the availability of capital and financing;
  • restrictive covenants in the Company’s credit facilities;
  • changes in the Company’s credit ratings;
  • HTA’s ability to remain qualified as a REIT;
  • changes in accounting principles generally accepted in the United States of America, policies and guidelines applicable to REITs; and
  • the risk factors set forth in HTA’s most recent Annual Report on Form 10-K and in HTA’s most recent Quarterly Reports on Form 10-Q.

Forward-looking statements speak only as of the date made.  Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.

Financial Contact:
Robert A. Milligan
Chief Financial Officer
Healthcare Trust of America, Inc.
480.998.3478
[email protected] 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-announces-its-first-quarter-dividend-301247577.html

SOURCE Healthcare Trust of America, Inc.

New Report Shows Marine Energy Has Potential to Power 220 Million U.S. Homes

Leveraging just one-tenth of available marine energy resources would equate to 5.7% of U.S electricity generation

Washington, D.C., March 15, 2021 (GLOBE NEWSWIRE) — Recognizing the value of America’s next-generation renewable, the U.S. Department of Energy (DOE) and the National Renewable Energy Laboratory (NREL) have issued a new report that identifies the potential of marine energy resources (wave, tidal, ocean current, ocean thermal, and riverine marine) titled Marine Energy in the United States: An Overview of Opportunities. Utilizing national and state level data, the report finds that the total marine energy technical resource in the 50 states to be 2,300 TWh/yr or the equivalent to roughly 57% of 2019 U.S. electricity generation – enough to power 220 million U.S. homes.

“The new report demonstrates that marine energy technologies could be the missing link for meeting our nation’s clean energy goals and decarbonizing our electricity grid,” said Malcolm Woolf, NHA President and CEO. “Much like the development of solar energy, with each passing day, marine energy moves one step closer to full scale commercialization.  We believe that the marine energy industry is poised for gigawatt (GW) scale deployment in the United States in the coming decade. President Biden and Congress have proposed an ambitious target of achieving 100 percent clean electricity by 2035, and tapping into just a fraction of marine energy’s potential could help make that a reality. ”

Report Pinpoints National, Regional and State Potential

In the report, NREL identified specific areas within the U.S. where marine energy devices could be deployed and its potential contribution for generation. For example,

  • On the West Coast, wave energy would be the dominant source, where there is a potential for 250 TWh/yr, which is equivalent to 67% of the region’s net electricity generation in 2019, enough to power 23 million homes.
  • On the East Coast, ocean thermal would be the dominant source, where there is a potential 460 TWh/y, which is equivalent to 49% of the region’s net electricity generation in 2019 enough to power 43-million homes.

Ongoing U.S Marine Energy Device Deployments

Throughout the country, marine energy developers are working to develop and deploy new power generation devices. For example, last October, Verdant Power deployed its TriFrame® Mounted Gen-5 Tidal Turbines, in New York City’s East River. To date, the device has exceeded expectations and generated 100 MWh in only the first 85 days of continuous operation, a record for marine energy production in the United States. This is far earlier than projected, which means the demonstration project is on track to generate more than 430 MWh in one year of operation.

In Igiugig, Alaska, the Ocean Renewable Power Company (ORPC) has demonstrated its 40-kW RivGen® Power System in the Kvichak River. It operated throughout 2020 and proved its ability to survive the harsh Alaskan winters. A second RivGen® Power System is being prepared for deployment at Igiugig this summer.

“Marine energy isn’t theoretical anymore, as innovations within the industry are leading to deployments that are proving the viability of the technologies” said Woolf. “One of the most significant challenges to the domestic marine energy industry is the need to continually attract private investment to fund innovation and initial demonstrations during the pre-competitive stages of technology development, primarily due to the timelines and technical risks involved. As with more mature power generation technologies, such as advanced gas turbines or solar converter systems, support from the U.S. Federal Government for critical early stage innovation and technology deployment efforts is key to igniting commercialization of the marine energy industry.”

Research Leads the March Towards Commercialization

For domestic marine energy developers, research and testing devices remains front and center. Assisting this effort, today, there are now four National Marine Energy Centers: Pacific Marine Energy Center (Oregon State University, University of Washington, and the University of Alaska Fairbanks); Southeast National Marine Renewable Energy Center at Florida Atlantic University; Hawaii National Marine Renewable Energy Center at the University of Hawaii; and Atlantic Marine Energy Center based at the University of New Hampshire.

Additionally, on March 1, 2021, the Federal Energy Regulatory Commission (FERC) issued a 25-year hydroelectric production license for Oregon State University’s PacWave South testing facility to deploy and test technologies to generate energy from ocean waves. It’s FERC’s first-ever license for a wave energy facility.  The ability to test devices in the unforgiving waters of the Pacific Ocean, about 6 nautical miles off the coast of Newport, Oregon, is expected to go a long way in proving the viability of devices.

“Establishing and expanding critical testing infrastructure, including grid connection and deployment equipment, for pre-commercial marine energy devices along with support for technology validation activities is critical to moving forward,” said Woolf. “We are encouraged by the network of U.S. companies, supported by universities and the National Labs, that are working to unlock the global marine energy resource and the new Blue Economy.”

About NHA

The National Hydropower Association (NHA) is a nonprofit association dedicated exclusively to promoting the growth of clean, renewable hydropower and marine energy. On April 28-30, NHA will be hosting the virtual International Conference on Ocean Energy (ICOE) 2021, supported by the International Energy Agency (IEA) through Ocean Energy Systems (OES). Every two years, ICOE brings together international stakeholders, experts and exhibitors from the marine energy sectors (tidal, wave, ocean currents, ocean thermal gradients) to discuss device innovation, new market developments and regulatory frameworks to spur commercialization. This is the first time the United States has hosted this important international event. For more information on ICOE 2021 visit www.icoe2021.org.

 

###



LeRoy Coleman
National Hydropower Association
2027508405
[email protected]